|
|
40
|
|
|
4181U
|
|
|
KADCYLA 160MG/ML INJ (ROC/AHI) ADO-TRASTUZUMAB EMTANSINE
|
|
|
ADO-TRASTUZUMAB EMTANSINE
|
|
|
KADCYLA
|
|
|
20ML
|
|
|
C
|
|
|
9,351.03
|
|
|
9,351.03
|
|
|
160MG/ML
|
|
|
INJECTION
|
|
|
0
|
|
|
VIAL
|
|
|
ROC
|
|
|
ROCHE SERVICIOS S.A.
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
Anti-Neoplastic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|